Thrombogenics N.V. | Key People and Executives
Patrik de Haes
Chief Executive Officer & Executive Director
Paul G. Howes
Non-Executive Director
Tom Moragne Clay
Chairman
Philippe Vlerick
Independent Non-Executive Director
Emmanuèle Attout
Independent Non-Executive Director
David R. Guyer
Independent Non-Executive Director
Patrik de Haes
Chief Executive Officer & Executive Director
Dominique Vanfleteren
Chief Financial Officer
Susan Schneider
Chief Medical Officer
Vinciane Vangeersdaele
Chief Commercial Officer
Claude Sander
Secretary, Chief Legal & Compliance Officer
Paul G. Howes
Non-Executive Director
Wouter Piepers
Global Head-Corporate Communications
Tom Moragne Clay
Chairman
Philippe Vlerick
Independent Non-Executive Director
Emmanuèle Attout
Independent Non-Executive Director
David R. Guyer
Independent Non-Executive Director
| Address |
Gaston Geenslaan 1
Leuven VL 3001
Belgium
|
|
Employees
|
- |
| Website |
http://www.oxurion.com |
| Updated |
07/08/2019 |
| ThromboGenics NV is a biopharmaceutical company, which engages in developing and commercializing medicines for the treatment of vitreo retinal diseases. It operates under JETREA (ocriplasmin) brand name. The company was founded by Desire Collen in 1991 and is headquartered in Leuven, Belgium. |
